Brain & cognition
5-HTP converts directly to serotonin. Small, mostly older trials report effects on mood, sleep and appetite; the serious risk is serotonin syndrome when combined with antidepressants.
Key takeaways
Most people reach for melatonin when they can’t sleep, or antidepressants when they’re struggling with mood. But there’s a middle layer in your serotonin biology that rarely gets discussed — a compound called 5-hydroxytryptophan (5-HTP) that sits one metabolic step away from serotonin itself, crosses the blood-brain barrier freely, and has a longer research history than most supplements sold for mood or sleep — mostly small trials from the 1970s to 1990s.
This isn’t another article that tells you serotonin makes you happy. It’s a close look at what 5-HTP actually does, what the research supports, where the real risks are, and how to use it intelligently.
Your brain makes serotonin from the amino acid tryptophan, but it’s a two-step process:
L-Tryptophan → 5-HTP → Serotonin
The first step — converting tryptophan to 5-HTP via the enzyme tryptophan hydroxylase — is rate-limiting. That means even if you eat a tryptophan-rich diet, your brain’s serotonin production is capped by how fast this enzyme works. It’s also subject to competition: tryptophan competes with other large neutral amino acids (leucine, valine, phenylalanine) for transport across the blood-brain barrier. A high-protein meal can actually reduce how much tryptophan reaches the brain.
5-HTP sidesteps the first bottleneck entirely. It doesn’t compete with other amino acids for brain transport — it uses a dedicated aromatic amino acid transporter with high affinity and low competition. Once inside the brain, the enzyme aromatic L-amino acid decarboxylase (AADC) converts it to serotonin almost immediately.
The practical implication: supplementing 5-HTP is a more direct and reliable route to raising central serotonin than supplementing tryptophan or eating turkey.
The most studied application of 5-HTP is depression. Open and controlled trials from the 1970s and 1980s, reviewed by van Praag, reported mood improvements with 5-HTP, but they were small and methodologically weak. More notable was a 1991 Swiss trial (Pöldinger et al.) that directly compared 5-HTP (300 mg/day) to fluvoxamine (a standard SSRI) over six weeks in 63 patients with depression. Both groups improved significantly — and the 5-HTP group did slightly better on Hamilton scores with fewer side effects — though the trial had no placebo arm, so it cannot show that either treatment worked.
The 2002 Cochrane review (Shaw et al.) found only two of 108 studies met its quality criteria; it concluded the evidence was insufficient to recommend 5-HTP and called for larger trials. The general picture: a few small, older trials suggest 5-HTP may improve mood scores in mild-to-moderate depression, but the evidence is insufficient to recommend it, and depression should be assessed and treated with a clinician. It is not a replacement for prescribed treatment at any severity.
Important caveat: 5-HTP should not be combined with SSRIs, SNRIs, MAOIs, or other serotonergic drugs due to serotonin syndrome risk (covered in the safety section below).
If you are experiencing persistent low mood or thoughts of harming yourself, contact a clinician or a crisis line; 5-HTP is not a treatment for depression.
Serotonin is a precursor to melatonin — specifically, the pineal gland converts serotonin to melatonin via two enzymatic steps when darkness falls. This means raising central serotonin via 5-HTP can enhance melatonin production rather than replacing it with an exogenous dose.
A notable 2010 pilot study (Shell et al.) tested a combination of 5-HTP (5 mg) and GABA (100 mg) versus placebo in subjects with sleep disorders. The combination shortened time to fall asleep and increased sleep duration and quality scores versus placebo in a small trial of a proprietary product (Shell et al. 2010); the 5-HTP dose was only 5 mg. Though the doses used were smaller than typical standalone 5-HTP dosing, the synergy with GABA is worth noting.
The mechanism here is distinct from melatonin supplementation. Rather than overriding your circadian clock with an exogenous hormone, 5-HTP supports the upstream serotonin pool that your brain uses to make melatonin on its own schedule. This is particularly relevant for people whose sleep problems stem from insufficient serotonin production rather than circadian misalignment.
Serotonin plays a major role in appetite regulation — specifically, 5-HT2C receptors in the hypothalamus reduce food intake and promote satiety. Several drugs developed for obesity (lorcaserin and fenfluramine — both later withdrawn for safety reasons) worked via serotonergic mechanisms. 5-HTP may produce similar, if milder, effects.
A landmark 1992 Italian study (Cangiano et al.) randomized 20 obese subjects to 900 mg/day of 5-HTP or placebo for 12 weeks during a calorie-restricted diet. The 5-HTP group lost significantly more weight than the placebo group over the 12 weeks — and notably, the 5-HTP group complied better with their diet, suggesting appetite suppression rather than just metabolic effects.
A follow-up trial in 1998 (Cangiano et al.) in diabetic patients found similar results: 5-HTP significantly reduced carbohydrate and fat intake, with subjects reporting reduced appetite and earlier satiety.
These are two small trials from a single research group in the 1990s; they suggest 5-HTP may reduce food intake, but no modern trial has repeated the result. The evidence is far too thin to call it an established appetite suppressant.
Some evidence suggests 5-HTP reduces anxiety, though this is less robust than the mood and sleep data. A 2002 study found that 5-HTP (200 mg) attenuated anxiety responses to carbon dioxide inhalation — a standard anxiety provocation test — in patients with panic disorder. The proposed mechanism is serotonin’s moderating influence on the amygdala and HPA axis stress response.
A 1990 Italian trial (Caruso et al.) tested 5-HTP (300 mg/day) against placebo in 50 fibromyalgia patients for 30 days, with a later 90-day open-label follow-up. Significant improvements were found across all five outcome measures: number of tender points, anxiety, pain intensity, quality of sleep, and fatigue. It has never been repeated in a modern trial, and fibromyalgia should be managed with a clinician; this is a single old study, not an established use.
| Factor | 5-HTP | L-Tryptophan |
|---|---|---|
| Steps to serotonin | 1 | 2 |
| BBB transport competition | Low (dedicated transporter) | High (competes with BCAAs) |
| Clinical evidence (mood) | More direct, stronger | Moderate |
| Peripheral serotonin conversion | Higher risk | Lower (more kynurenine pathway use) |
| Cost | Moderate | Moderate |
| Recommended use | Mood, sleep, appetite | General serotonin support |
The key difference is peripheral vs. central conversion. Because 5-HTP converts readily to serotonin in the gut and periphery (not just the brain), more of the dose raises central vs. peripheral serotonin when taken without a peripheral decarboxylase inhibitor (see dosing section). L-Tryptophan has a more distributed conversion pathway — more gets shunted into the kynurenine pathway and less reaches serotonin synthesis.
For raising serotonin directly, 5-HTP is the more direct precursor; the clinical evidence for either compound is limited.
| Study area | Doses used in trials | Range across trials | Timing used |
|---|---|---|---|
| Mood support | 50 mg | 50–300 mg/day | Morning or split doses |
| Sleep onset | 100–200 mg | 100–300 mg | 30–60 min before bed |
| Appetite / satiety | 100 mg | 300–900 mg/day | 30 min before each meal |
Nausea is the most common side effect and is dose-dependent; trials that started participants at low doses with food reported less GI discomfort. Anyone considering it should discuss the dose with a clinician, especially if taking any medication.
For sleep specifically, take 5-HTP 30–60 minutes before bed. The serotonin→melatonin conversion happens in the dark-exposed pineal gland — you want serotonin availability peaking as darkness falls and melatonin production ramps up.
For mood, morning dosing or splitting across morning and afternoon is preferable to avoid potential insomnia from raising serotonin during the day (paradoxically, evening serotonin can be stimulating for some people before it converts to melatonin).
For appetite, pre-meal dosing (20–30 minutes before eating) has the most direct satiety evidence.
A commonly mentioned strategy is taking 5-HTP with a peripheral DOPA decarboxylase inhibitor like carbidopa. The theory: if you block peripheral conversion of 5-HTP to serotonin (in the gut, blood, and tissue), more reaches the brain, improving central serotonin levels and reducing peripheral side effects.
This was how some clinical trials were designed, under medical supervision. Carbidopa is a prescription drug used in Parkinson’s disease, and the 5-HTP–carbidopa pairing has been linked to scleroderma-like reactions in case reports (Sternberg 1980); it is not a strategy for supplement users. The practical takeaway for most people: taking 5-HTP with food (especially a small carbohydrate snack, which raises insulin and clears competing amino acids) may improve brain uptake without needing a pharmaceutical inhibitor.
This is where most articles fail to give useful guidance. Long-term continuous 5-HTP use raises two concerns:
Receptor downregulation: Chronic elevation of serotonin can downregulate 5-HT receptors, reducing efficacy over time. This is the same mechanism that causes tolerance to SSRIs. Whether this happens with 5-HTP at supplement doses has not been studied.
Dopamine depletion: 5-HTP is converted by the same enzyme (AADC) that converts L-DOPA to dopamine. High-dose continuous 5-HTP supplementation can competitively reduce dopamine synthesis. This concern is theoretical, drawn from case reports and animal work; there is no trial showing that adding tyrosine or L-DOPA precursors prevents it, and stacking precursors is not something to attempt without clinical advice.
No trial has tested a cycling schedule; the ‘4–6 weeks on, 2–4 weeks off’ pattern circulating online is community practice, not evidence.
Commercial 5-HTP is extracted from the seeds of Griffonia simplicifolia, a West African shrub that accumulates 5-HTP at concentrations up to 20% of seed dry weight. This is a natural plant source — not synthetic — and virtually all 5-HTP on the market is derived this way.
Quality varies. Look for: - Standardized Griffonia simplicifolia seed extract - Third-party tested (NSF, USP, or Informed Sport) - No artificial fillers or proprietary blends masking dosage - Enteric-coated capsules if nausea is a concern
This is the most serious risk — not hypothetical. Combining 5-HTP with any drug that increases serotonergic tone can trigger serotonin syndrome, ranging from uncomfortable (shivering, diarrhea, tremor) to life-threatening (hyperthermia, seizures, loss of consciousness).
Absolute contraindications: - SSRIs (fluoxetine, sertraline, escitalopram, etc.) - SNRIs (venlafaxine, duloxetine) - MAOIs (phenelzine, tranylcypromine, selegiline) - Tramadol - Dextromethorphan (found in many cough medicines) - Triptans (sumatriptan, rizatriptan) — increased risk - St. John’s Wort — modest but real risk when combined
Exercise caution with: - Lithium - Linezolid (antibiotic with MAOI activity) - Methylene blue (used in some medical procedures)
Insufficient safety data. Avoid during pregnancy — serotonin plays developmental roles that make supplementation unwise without medical supervision.
In the late 1980s, a contaminated batch of L-tryptophan caused an outbreak of EMS, a serious connective tissue disorder. This raised concerns that were briefly applied to 5-HTP. However, the cause was a specific manufacturing contaminant (“peak X”) in one L-tryptophan producer, not tryptophan itself. 5-HTP has not been similarly implicated, and no EMS cluster has been attributed to Griffonia-derived 5-HTP.
In 1998 researchers reported trace ‘peak X’ impurities in some over-the-counter 5-HTP products (Williamson et al., Nat Med) and the FDA issued a public notice; no EMS cluster has been tied to Griffonia-derived 5-HTP since. Purchase only from reputable manufacturers with current third-party testing.
Nausea, cramping, and diarrhea are common at higher doses and almost always dose-dependent. Taking 5-HTP with food substantially reduces GI side effects. If nausea persists at doses below 100 mg, consider L-tryptophan as an alternative.
Who the studies included: - Adults with mild-to-moderate depressive symptoms in small 1970s–90s trials (not on antidepressants) - Adults with sleep-onset complaints (one small combination-product trial) - Obese adults on a calorie-restricted diet (two small trials) - Fibromyalgia patients in one 1990 trial (not an established use; see a clinician) - Panic-disorder patients in one laboratory challenge study
If you have persistent low mood or anxiety, see a clinician — these are not conditions to self-treat with a supplement.
Not appropriate for: - Anyone taking SSRIs, SNRIs, MAOIs, or tramadol - Pregnant or breastfeeding women - Anyone with bipolar disorder (serotonin shifts can trigger episodes — work with a clinician) - Children
Use with caution: - People with a history of kidney or liver disease - Anyone with a personal or family history of cardiac arrhythmias (peripheral serotonin affects platelet aggregation and vascular tone)
| Supplement | Primary Mechanism | Evidence Strength | Best Use Case |
|---|---|---|---|
| 5-HTP | Serotonin precursor | Small, dated trials | Mood, sleep, appetite |
| Magnesium L-Threonate | NMDA modulation, GABA | ★★★☆☆ | Sleep quality, anxiety |
| Ashwagandha | HPA axis modulation, GABA | ★★★★☆ | Stress, cortisol, sleep latency |
| Glycine | Inhibitory NT, thermoregulation | ★★★☆☆ | Sleep quality, N-REM |
| Melatonin | Circadian signal | ★★★★☆ | Circadian reset, jet lag |
| L-Theanine | GABA, alpha waves | ★★★☆☆ | Anxiety, focus |
| Rhodiola Rosea | Monoamine modulation | ★★★☆☆ | Fatigue, stress |
5-HTP’s mood evidence is older and thinner than a star rating suggests — a handful of small trials — and it acts on a different mechanism from ashwagandha. Used together (assuming no SSRIs), they address complementary pathways: ashwagandha reduces cortisol-driven anxiety and HPA dysregulation; 5-HTP supports serotonergic tone directly.
5-HTP is not a supplement to take casually. The mechanism is direct and the older trials are suggestive — but the interaction profile demands that you understand what you’re combining it with.
If you are considering 5-HTP for occasional sleeplessness or low mood, talk to a clinician first — especially if you take any medication. The trials used 50–300 mg/day for a few weeks; no cycling schedule has been tested.
If you’re already on an SSRI or any serotonergic drug: full stop. This is not a supplement to add to your existing stack without direct supervision from a clinician who understands the interaction.
For most people without those contraindications, 5-HTP is one of the more mechanistically coherent mood and sleep supplements, with a small and dated evidence base — and it’s consistently underrated in conversations about the serotonin system.
Related reading: Ashwagandha: The Deep-Dive into the Most Evidence-Backed Adaptogen · Magnesium L-Threonate: Brain and Sleep Evidence Reviewed · Glycine: The Underrated Sleep Amino Acid
This article is for general education and is not medical advice. It does not replace a qualified clinician; talk to one before changing a supplement, medication or treatment, especially if you are pregnant, take medication or have a medical condition.
Related
Brain & cognition
One trial found a year of aerobic walking grew older adults' anterior hippocampus by 2 percent. Pooled trials say the honest word is 'preserve', and the memory gains are real but modest.
Brain & cognition
Phosphatidylserine improved memory scores in older adults in several small trials, but the FDA's 2003 qualified claim calls that evidence 'very limited and preliminary'. What the trials found and what the claim means.
Brain & cognition
Acetyl-L-carnitine crosses the blood-brain barrier more readily than plain L-carnitine. What trials in older adults found for memory, mood and nerve health, the doses used, and safety.
Readers
Comments
Leave a comment